Literature DB >> 24452385

The effect of the weather on pulmonary exacerbations and viral infections among adults with cystic fibrosis.

W G Flight1, R J Bright-Thomas, C Sarran, K J Mutton, J Morris, A K Webb, A M Jones.   

Abstract

The effect of changes in the weather on the respiratory health of patients with cystic fibrosis (CF) is unclear. We conducted a prospective study to determine the impact of climate and season on the incidence of viral respiratory infections (VRI) and pulmonary exacerbations (PEx) among adults with CF. Between December 2010 and April 2012, 98 adults with CF were followed for 12 months. Polymerase chain reaction assays for nine viruses were performed on sputum, nose and throat swabs every 2 months and additionally at onset of PEx. Hourly temperature and relative humidity measurements were recorded throughout the study. Statistical analysis utilized generalized estimating equation (GEE) models. Pre-specified criteria for VRI and PEx were met at 29% and 37% of visits, respectively. Rhinovirus accounted for 72% of identified viruses. Incidence of rhinovirus peaked in autumn while non-rhinovirus VRI peaked in winter. Rhinovirus was associated with increased mean temperatures (OR 1.07; p = 0.001), while non-rhinovirus VRI was associated with lower mean temperatures (OR 0.87; p < 0.001). PEx occurred frequently throughout the study with no clear seasonal pattern observed. There was no significant association between climate variables and the incidence of either PEx or antibiotic prescription. There is a seasonal pattern to VRI in adults with CF. The incidence of VRI but not PEx is associated with changes in ambient temperature.

Entities:  

Mesh:

Year:  2014        PMID: 24452385     DOI: 10.1007/s00484-013-0786-0

Source DB:  PubMed          Journal:  Int J Biometeorol        ISSN: 0020-7128            Impact factor:   3.787


  26 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Survival of human rhinovirus type 14 dried onto nonporous inanimate surfaces: effect of relative humidity and suspending medium.

Authors:  S A Sattar; Y G Karim; V S Springthorpe; C M Johnson-Lussenburg
Journal:  Can J Microbiol       Date:  1987-09       Impact factor: 2.419

3.  The September epidemic of asthma hospitalization: school children as disease vectors.

Authors:  Neil W Johnston; Sebastian L Johnston; Geoff R Norman; Jennifer Dai; Malcolm R Sears
Journal:  J Allergy Clin Immunol       Date:  2006-01-27       Impact factor: 10.793

4.  Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.

Authors:  C R Jenkins; B Celli; J A Anderson; G T Ferguson; P W Jones; J Vestbo; J C Yates; P M A Calverley
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

5.  Rhinovirus infections in an industrial population. I. The occurrence of illness.

Authors:  J M Gwaltney; J O Hendley; G Simon; W S Jordan
Journal:  N Engl J Med       Date:  1966-12-08       Impact factor: 91.245

6.  Influence of season on exacerbation characteristics in patients with COPD.

Authors:  Gavin C Donaldson; James J Goldring; Jadwiga A Wedzicha
Journal:  Chest       Date:  2011-07-28       Impact factor: 9.410

7.  Influence of air pressure, humidity, solar radiation, temperature, and wind speed on ambulatory visits due to chronic obstructive pulmonary disease in Bavaria, Germany.

Authors:  Uta Ferrari; Teresa Exner; Eva R Wanka; Christoph Bergemann; Julian Meyer-Arnek; Beate Hildenbrand; Amanda Tufman; Christian Heumann; Rudolf M Huber; Michael Bittner; Rainald Fischer
Journal:  Int J Biometeorol       Date:  2011-02-08       Impact factor: 3.787

8.  Influenza-associated cystic fibrosis pulmonary exacerbations.

Authors:  Justin R Ortiz; Kathleen M Neuzil; John C Victor; Anna Wald; Moira L Aitken; Christopher H Goss
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

9.  The relationship between indoor and outdoor temperature, apparent temperature, relative humidity, and absolute humidity.

Authors:  J L Nguyen; J Schwartz; D W Dockery
Journal:  Indoor Air       Date:  2013-06-18       Impact factor: 5.770

10.  Absolute humidity modulates influenza survival, transmission, and seasonality.

Authors:  Jeffrey Shaman; Melvin Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

View more
  5 in total

1.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

Review 2.  Respiratory Viral Infections in Chronic Lung Diseases.

Authors:  Clemente J Britto; Virginia Brady; Seiwon Lee; Charles S Dela Cruz
Journal:  Clin Chest Med       Date:  2016-12-24       Impact factor: 2.878

3.  Meteorological Factors Influence the Presence of Fungi in the Air; A 14-Month Surveillance Study at an Adult Cystic Fibrosis Center.

Authors:  Norman van Rhijn; James Coleman; Lisa Collier; Caroline Moore; Malcolm D Richardson; Rowland J Bright-Thomas; Andrew M Jones
Journal:  Front Cell Infect Microbiol       Date:  2021-11-26       Impact factor: 5.293

Review 4.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

5.  Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations.

Authors:  Tavs Qvist; Daniela K Schlüter; Vian Rajabzadeh; Peter J Diggle; Tania Pressler; Siobhán B Carr; David Taylor-Robinson
Journal:  J Cyst Fibros       Date:  2018-10-19       Impact factor: 5.482

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.